Eli Lilly to supply COVID-19 antibody treatment to US for $375 million - Business Insider

Eli Lilly has agreed to supply 300,000 vials of its COVID-19 antibody treatment in the US, pending the treatment's emergency approval by the Food and Drug Administration .It said the therapy, bamlanivimab, would be used in "high-risk" patients with mild-to-moderate COVID-19.

Eli Lilly said Wednesday it expects to manufacture 1 million doses of the antibody treatment by the end of year, with 100,000 doses ready to ship worldwide soon after authorization.The US government will initially pay $375 million for 300,000 vials of the antibody treatment if the FDA grants it an emergency use authorization , Eli Lilly said."The initial agreement is for delivery over the two months following an EUA and also provides the option for the U.S.

Hope they get a thank you card, is this the wholesale price we paying 🧐.

good

FFS it doesn't work. Trust big pharma?

Brasil Últimas Notícias, Brasil Manchetes

Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.

Inside independent ad agency The Richards Group's problematic culture - Business InsiderBusiness Insider is a fast-growing business site with deep financial, media, tech, and other industry verticals. Launched in 2007, the site is now the largest business news site on the web.
Fonte: BusinessInsider - 🏆 729. / 51 Consulte Mais informação »

Inside yachting's sexual harassment and bullying problem - Business InsiderBusiness Insider is a fast-growing business site with deep financial, media, tech, and other industry verticals. Launched in 2007, the site is now the largest business news site on the web. capthlr how true is this?
Fonte: BusinessInsider - 🏆 729. / 51 Consulte Mais informação »